Profil

VAIRA Dolorès

Unilab > Unité de laboratoire - LRS Biomol

See author's contact details
Main Referenced Co-authors
Moutschen, Michel  (39)
Rentier, Bernard  (28)
Gerard, Christiane  (26)
Delwaide, Jean  (25)
Darcis, Gilles  (20)
Main Referenced Keywords
Humans (18); HIV (10); Adult (6); Genotype (6); HIV-1 (6);
Main Referenced Unit & Research Centers
CHU de Liège (1)
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège [BE] (1)
Laboratoire de Référence Sida (1)
Main Referenced Disciplines
Immunology & infectious disease (65)
Gastroenterology & hepatology (17)
Surgery (5)
Biochemistry, biophysics & molecular biology (5)
Laboratory medicine & medical technology (4)

Publications (total 97)

The most downloaded
765 downloads
Gielen, S., Delwaide, J., Detry, O., Belaiche, J., Honore, P., Gerard, C., Maggipinto, G., Vaira, D., & Rentier, B. (2001). Comment je traite une ascite. Revue Médicale de Liège, 56 (12), 809-815. https://hdl.handle.net/2268/69781

The most cited

217 citations (Scopus®)

Reuse, S., Calao, M., Kabeya, K., Guiguen, A., GATOT, J.-S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D., Demonte, D., Martinelli, V., Veithen, E., Cherrier, T., Avettand, V., Poutrel, S., Piette, J., de Launoit, Y., Moutschen, M., Burny, A., ... Van Lint, C. (2009). Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS ONE, 4 (6), 6093. doi:10.1371/journal.pone.0006093 https://hdl.handle.net/2268/28447

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (11 September 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. HIV Cure Symposium 2023, Gand, Belgium.

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (21 February 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Conference on Retroviruses and Opportunistic Infection (CROI 2023), Seattle, United States.

Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (23 November 2022). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Belgium Research on AIDS and HIV Consortium (BREACH 2022), Bruxelles, Belgium.

El Moussaoui, M., Maes, N., Fombellida, K., VAIRA, D., Moutschen, M., & Darcis, G. (02 September 2022). Impact de la pandémie de Covid-19 sur les soins de santé des personnes vivant avec le VIH à Liège, Belgique [Paper presentation]. Congrès annuel de l'Association Latine pour l'Analyse des Systèmes de Santé (CALASS), Barcelone, Spain.
Peer reviewed

Van Beckhoven, D., Serrien, B., Montourcy, M., Verhofstede, C., Van den Bossche, D., Libois, A., De Geyter, D., Martin, T., Van den Eynde, S., Vuylsteke, B., Darcis, G., van Halem, K., Florence, E., Deblonde, J., Ausselet, N. (Other coll.), Delforge, M.-L. (Other coll.), Demeester, R. (Other coll.), De Munter, P. (Other coll.), Goffard, J.-C. (Other coll.), ... Yombi, J.-C. (Other coll.). (2022). Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care. BMC Infectious Diseases, 22 (1), 901. doi:10.1186/s12879-022-07879-1
Peer Reviewed verified by ORBi

El Moussaoui, M., Lambert, N., MAES, N., Fombellida, K., VAIRA, D., MOUTSCHEN, M., & DARCIS, G. (30 November 2021). Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium [Poster presentation]. BREACH Symposium 2021, Bruxelles, Belgium.

El Moussaoui, M., Lambert, N., MAES, N., Fombellida, K., VAIRA, D., MOUTSCHEN, M., & DARCIS, G. (2021). Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium. HIV Research & Clinical Practice. doi:10.1080/25787489.2021.1948773
Peer Reviewed verified by ORBi

Plum, P.-E., Maes, N., Sauvage, A.-S., Frippiat, F., Meuris, C., Uurlings, F., Lecomte, M., Léonard, P., Paquot, N., Fombellida, K., Vaira, D., Moutschen, M., & Darcis, G. (2021). Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV. BMC Infectious Diseases, 21 (1), 910. doi:10.1186/s12879-021-06479-9
Peer Reviewed verified by ORBi

Hayette, M.-P., MEEX, C., BONTEMS, S., Diop, C. S., NIZET, A., Lamtiri Laarif, M., DESCY, J., VAIRA, D., Jacques, J., Thys, M., GILLET, P., & MELIN, P. (September 2020). La déferlante COVID-19 : la PCR à la rescousse ! : Chronique d’une gestion de crise au Laboratoire de Microbiologie clinique du CHU de Liège. Revue Médicale de Liège, 75 (S55-S61), 55-61.
Peer reviewed

Fombellida-Lopez, C., Chaslain, A., SUSIN, F., VAIRA, D., Moutschen, M., & DARCIS, G. (September 2020). Obstacles à la guérison de l'infection par le VIH. Partie 1 : les réservoirs latents. Revue Médicale de Liège, 75 (9), 573-577.
Peer reviewed

Chaslain, A., Fombellida-Lopez, C., SUSIN, F., VAIRA, D., Moutschen, M., & Darcis, G. (September 2020). Obstacles à la guérison de l'infection par le VIH. Partie 2 : la réplication continue malgré le traitement. Revue Médicale de Liège, 75 (9), 582-587.
Peer reviewed

Stoffels, K., Vanroye, F., Mortier, V., Debaisieux, L., Delforge, M.-L., Depypere, M., Dessilly, G., VAIRA, D., Vancutsem, E., Van Den Wijngaert, S., Van Laethem, K., Vercauteren, K. O. A., Verhofstede, C., & Fransen, K. (20 May 2020). Chronic and Early Antiretroviral Therapy Impact Human Immunodeficiency Virus (HIV) Serological Assay Sensitivity, Leading to More False-Negative Test Results in HIV Diagnosis. Journal of Infectious Diseases, 222 (10), 1660-1669. doi:10.1093/infdis/jiaa271
Peer Reviewed verified by ORBi

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., Moutschen, M., & Darcis, G. (2020). Evolution of Drug Interactions With Antiretroviral Medication in People With HIV. Open Forum Infectious Diseases, 7 (11), 416. doi:10.1093/ofid/ofaa416
Peer Reviewed verified by ORBi

DARCIS, G., VAIRA, D., & MOUTSCHEN, M. (2020). Impact of coronavirus pandemic and containment measures on HIV diagnosis. Epidemiology and Infection. doi:10.1017/S0950268820001867
Peer reviewed

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., FOMBELLIDA, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (22 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Poster presentation]. 8th BREACH SYMPOSIUM, Liège, Belgium.

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (08 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Paper presentation]. 17th European AIDS Conference, Bâle, Switzerland.

DARCIS, G., MAES, N., Pasternak, A., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., El Moussaoui, M., Fombellida, K., VAIRA, D.* , & MOUTSCHEN, M.*. (2019). Detectability of HIV residual Viremia despite therapy is highly associated with treatment with a protease inhibitor-based combination antiretroviral therapy. Antimicrobial Agents and Chemotherapy. doi:10.1128/AAC.01902-19
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

DARCIS, G., Lambert, I., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., GIOT, J.-B., fombellida, K., VAIRA, D., & MOUTSCHEN, M. (2018). Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017. Scientific Reports. doi:10.1038/s41598-018-26852-0
Peer Reviewed verified by ORBi

Verhofstede, C., Dauwe, K., Fransen, K., Van Laethem, K., Van Den Wijngaert, S., Ruelle, J., Delforge, M.-L., Vancutsem, E., VAIRA, D., Stoffels, K., Garcia Ribas, S., Dessilly, G., Debaisieux, L., Piérard, D., Van Ranst, M., Hayette, M.-P., Deblonde, J., Sasse, A., Van Beckhoven, D., & Mortier, V. (2018). Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migrant communities. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases. doi:10.1016/j.meegid.2018.03.002
Peer Reviewed verified by ORBi

DE VOEGHT, A., Martens, H., RENARD, J. D. C., VAIRA, D., Debruche, M., Simonet, J., Geenen, V., MOUTSCHEN, M., & DARCIS, G. (2017). Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium. PLoS ONE. doi:10.1371/journal.pone.0185761
Peer Reviewed verified by ORBi

Adawaye, C., Fokam, J., Kamangu, E., Alio, H. M., Chahad, A. M., SUSIN, F., Moussa, A. M., Bertin, T. H. Z., Tidjani, A., VAIRA, D., & Moutschen, M. (2017). Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: Findings from a cross-sectional study. BMC Research Notes, 10 (1). doi:10.1186/s13104-017-2893-1
Peer Reviewed verified by ORBi

KAMANGU, E., CHATTE, A., BOREUX, R., SUSIN, F., KALALA, R., Mwumbi, G. L., De Mol, P., Hayette, M.-P., & VAIRA, D. (March 2015). Comparison of an In-House Quantitative Real-Time PCR and COBAS ampliprep/Taqman Roche for determination of viral load for HIV type 1 non-b. Open Access Library Journal, 2 (e1402). doi:10.1186/1742-4690-9-S1-P146
Peer reviewed

Van Beckhoven, D., Florence, E., Ruelle, J., Deblonde, J., Verhofstede, C., Callens, S., Vancutsem, E., Lacor, P., Demeester, R., Goffard, J.-C., Sasse, A., De Wit, S., Vogelaers, D., Delforge, M.-L., Florence, E., Fransen, K., Goffard, J.-C., Hayette, M.-P., Lacor, P., ... Verhofstede, C. (2015). Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants. BMC Infectious Diseases, 15 (1). doi:10.1186/s12879-015-1230-3
Peer Reviewed verified by ORBi

Kamangu, E., Adawaye, C. I., BOREUX, R., Lunkanza, R., Georges, L. M., VAIRA, D., & HAYETTE, M.-P. (12 October 2014). Implementation of an In-House Quantitative Real-Time PCR for Determination of HIV Viral Load in Kinshasa. Open Access Library Journal, 1, 1-5.

Frentz, D., Van de Vijver, D. A., Abecasis, A. B., Albert, J., Hamouda, O., Jorgensen, L. B., Kucherer, C., Struck, D., Schmit, J.-C., Vercauteren, J., Balotta, C., Beshkov, D., Camacho, R., Clotet, B., Coughlan, S., Griskevicius, A., Grossman, Z., Horban, A., Kolupajeva, T., ... VAIRA, D. (Other coll.). (21 July 2014). Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infectious Diseases, 14 (407), 1-12. doi:10.1186/1471-2334-14-407
Peer Reviewed verified by ORBi

Singh, M., Singh, P., VAIRA, D., Torheim, E. A., Rahmouni, S., Tasken, K., & MOUTSCHEN, M. (February 2014). The RIAD peptidomimetic inhibits HIV-1 replication in humanized NSG mice. European Journal of Clinical Investigation, 44 (2), 146-152. doi:10.1111/eci.12200
Peer Reviewed verified by ORBi

DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Clumeck, N., Rohr, O., MOUTSCHEN, M., Corrazza, F., Rouzioux, C., De Wit, S., & Van Lint, C. (2014). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-kB signaling pathway [Paper presentation]. 20th AIDS international conference, Melbourne, Australia.

Megens, S., VAIRA, D., De Baets, G., Dekeersmaeker, N., Schrooten, Y., Li, G., Schymkowitz, J., Rousseau, F., Vandamme, A.-M., Moutschen, M., & Van Laethem, K. (2014). Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication deficits. Virology, 456-457, 310-8. doi:10.1016/j.virol.2014.03.023
Peer Reviewed verified by ORBi

Singh, M., Singh, P., VAIRA, D., Amand, M., Rahmouni, S., & Moutschen, M. (2014). Minocycline attenuates HIV-1 infection and suppresses chronic immune activation in humanized NOD/LtsZ-scidIL-2Rgamma(null) mice. Immunology, 142 (4), 562-72. doi:10.1111/imm.12246
Peer Reviewed verified by ORBi

Clumeck, N., Mwamba, C., Kabeya, K., Matanda, S., VAIRA, D., Necsoi, C., Kadiebwe, D., Delforge, M., Kasamba, E., Milolo, C., Ilunga, J., & Kapend, L. (2014). First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting. AIDS, 28 (8), 1143-53. doi:10.1097/QAD.0000000000000214
Peer Reviewed verified by ORBi

Adawaye, C. I., Erick, K., Ali, M. M., Bertin, T., VAIRA, D., & MOUTSCHEN, M. (September 2013). Use of Dried Blood Spot to Improve the Diagnosis and Management of HIV in Resource-Limited Settings. World Journal of AIDS, 3, 251-256. doi:10.4236/WJA.2013.33033
Peer reviewed

Bouare, N., GOTHOT, A., DELWAIDE, J., BONTEMS, S., VAIRA, D., SEIDEL, L., Gerard, P., & GERARD, C. (April 2013). Epidemiological profiles of human immunodeficiency virus and hepatitis C virus infections in Malian women: risk factors and relevance of disparities. World Journal of Hepatology, 27 (5), 196-205. doi:10.4254/wjh.v5.i4.196
Peer Reviewed verified by ORBi

DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Herbein, G., Clumeck, N., Rohr, O., MOUTSCHEN, M., Rouzioux, C., De Wit, S., & Van Lint, C. (2013). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-B signaling pathway [Paper presentation]. First annual meeting Belgian Society for Virology.

Ortiou, S., BONTEMS, S., Servais, J.-Y., Perez-Bercoff, D., Fritz, J., VAIRA, D., DELWAIDE, J., Arendt, V., Staub, T., Schmit, J., & Devaux, C. (2013). Replication Capacity and Susceptibility to Telaprevir of the T54S Resistant Variant is Modulated by Others Hepatitis C Virus NS3 Mutations [Poster presentation]. XXVth BelgianWeek of gastroenterology, Anvers, Belgium.

DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Herbein, G., Clumeck, N., Rohr, O., MOUTSCHEN, M., Rouzioux, C., De Wit, S., & Van Lint, C. (2013). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-B signaling pathway [Paper presentation]. 14th European AIDS Conference (EACS), Brussels.

Bouare, N., VAIRA, D., GOTHOT, A., DELWAIDE, J., BONTEMS, S., SEIDEL, L., Gerard, P., & GERARD, C. (December 2012). Prevalence of HIV and HCV infections in two populations of Malian women and serological assays performances. World Journal of Hepatology, 4 (12), 365-73. doi:10.4254/wjh.v4.i12.365
Peer Reviewed verified by ORBi

BOUHARE, N., VAIRA, D., GOTHOT, A., DELWAIDE, J., BONTEMS, S., Seidel, L., Gerard, P., & GERARD, C. (2012). HCV screening in African (Malian) women : relevancy of the HCV NS3 epitope [Poster presentation]. 2nd congress on controversies in the management of viral hepatitis, Berlin, Germany.

Singh, M., Singh, P., Gaudray, G., Musumeci, L., Thielen, C., VAIRA, D., Vandergeeten, C., Delacroix, L., Van Gulck, E., Vanham, G., de Leval, L., Rahmouni, S., & MOUTSCHEN, M. (2012). An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rgammanull mice allows HIV replication and development of anti-HIV immune responses. PLoS ONE, 7 (6), 38491. doi:10.1371/journal.pone.0038491
Peer Reviewed verified by ORBi

BOUHARE, N., VAIRA, D., GOTHOT, A., DELWAIDE, J., Seidel, L., Gérard, P., SASSE, BONTEMS, S., & GERARD, C. (2012). Study of HCV and HIV infections in Mali: Comparative Epidemiology and Risk Factors [Poster presentation]. 2nd congress on controversies in the management of viral hepatitis, Berlin, Germany.

Singh, M., Singh, P., VAIRA, D., Tasken, K., Rahmouni, S., & Moutschen, M. (03 October 2011). Humanized mice as a useful model to study HIV-1 induced immune activation, its mechanisms and potential therapeutic approaches. Retrovirology, 8, 62.
Peer Reviewed verified by ORBi

LOLY, J., GERARD, C., VAIRA, D., LAMPROYE, A., Bastens, B., Servais, B., Wain, E., Bataille, C., & DELWAIDE, J. (March 2011). Evolution over a 15 year period of the epidemiological profile of 2884 newly diagnosed HCV patients in Belgium. Acta Gastro-Enterologica Belgica, 74, 50.
Peer Reviewed verified by ORBi

Vandekerckhove, L., Verhofstede, C., Demecheleer, E., De Wit, S., Florence, E., Fransen, K., Moutschen, M., Mostmans, W., Kabeya, K., Mackie, N., Plum, J., VAIRA, D., Van Baelen, K., Vandenbroucke, I., Van Eygen, V., Van Marck, H., Vogelaers, D., Geretti, A. M., & Stuyver, L. J. (2011). Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment. Journal of Antimicrobial Chemotherapy, 66 (2), 265-72. doi:10.1093/jac/dkq458

Verhofstede, C., Brudney, D., Reynaerts, J., VAIRA, D., Fransen, K., De Bel, A., Seguin-Devaux, C., De Wit, S., Vandekerckhove, L., & Geretti, A.-M. (2011). Concordance between HIV-1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA. HIV Medicine, 12 (9), 544-52. doi:10.1111/j.1468-1293.2011.00922.x
Peer Reviewed verified by ORBi

Putzeys, V., GERARD, C., Bastens, B., Wain, E., Bataille, C., Defrance, P., Belaiche, J., DE ROOVER, A., DETRY, O., Honoré, P., MAGGIPINTO, G., Rentier, B., VAIRA, D., & DELWAIDE, J. (2011). Hepatitis C of genotype 2: the role of medical invasive exams. Acta Gastro-Enterologica Belgica, 74 (2), 277-80.
Peer Reviewed verified by ORBi

Vandenbroucke, I., Van Marck, H., Mostmans, W., Van Eygen, V., Rondelez, E., Thys, K., Van Baelen, K., Fransen, K., Vaira, D., Kabeya, K., De Wit, S., Florence, E., Moutschen, M., Vandekerckhove, L., Verhofstede, C., & Stuyver, L. J. (2010). HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays. AIDS Research and Therapy, 7, 4. doi:10.1186/1742-6405-7-4
Peer Reviewed verified by ORBi

Reuse, S., Calao, M., Kabeya, K., Guiguen, A., GATOT, J.-S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D., Demonte, D., Martinelli, V., Veithen, E., Cherrier, T., Avettand, V., Poutrel, S., Piette, J., de Launoit, Y., Moutschen, M., Burny, A., ... Van Lint, C. (2009). Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS ONE, 4 (6), 6093. doi:10.1371/journal.pone.0006093
Peer Reviewed verified by ORBi

Garcia, M. V., Mukeba-Tshialala, D., Vaira, D., & Moutschen, M. (2009). Triom une: la tritherapie du pauvre ? Revue Médicale de Liège, 64 (1), 32-6.
Peer reviewed

Vercauteren, J., Derdelinckx, I., Sasse, A., Bogaert, M., Ceunen, H., De Roo, A., De Wit, S., Deforche, K., Echahidi, F., Fransen, K., Goffard, J.-C., Goubau, P., Goudeseune, E., Yombi, J.-C., Lacor, P., Liesnard, C., Moutschen, M., Piérard, D., Rens, R., ... van Laethem, K. (2008). Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006. AIDS Research and Human Retroviruses, 24 (3), 355-62. doi:10.1089/aid.2007.0212
Peer Reviewed verified by ORBi

Ruelle, J., Roman, F., Vandenbroucke, A.-T., Lambert, C., Fransen, K., Echahidi, F., Piérard, D., Verhofstede, C., Van Laethem, C., Delforge, M.-L., Vaira, D., Schmitz, J.-C., & Goubau, P. (2008). Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database. BMC Infectious Diseases, 8, 21. doi:10.1186/1471-2334-8-21
Peer Reviewed verified by ORBi

Chandrika, K., Dellot, P., Frippiat, F., Giot, J.-B., Leonard, P., Marée, R., Mayasi, N., Meuris, C., Mukeba Tshialala, D., Rahmouni, S., Uurlings, F., Vaira, D., Wehenkel, L., Demonty, J., & Moutschen, M. (2007). Nouvelles approches dans la prise en charge de l'infection a VIH. Revue Médicale de Liège, 62 Spec No, 47-50.
Peer reviewed

Zeddou, M., Rahmouni, S., Vandamme, A., Jacobs, N., Frippiat, F., Leonard, P., SCHAAF-LAFONTAINE, N., Vaira, D., Boniver, J., & Moutschen, M. (2007). Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts. Retrovirology, 4, 72. doi:10.1186/1742-4690-4-72
Peer Reviewed verified by ORBi

Delwaide, J., Reenaers, C., Gerard, C., Vaira, D., Bastens, B., Serwir, B., Bekhti, A., Bataille, C., Wain, E., De Leeuw, P., Daenen, G., Mesureur, T., Sente, J. M., & Belaiche, J. (July 2006). HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin. European Journal of Gastroenterology and Hepatology, 18 (7), 707-712. doi:10.1097/01.meg.0000219103.40435.8d
Peer Reviewed verified by ORBi

Delwaide, J., Gerard, C., Reenaers, C., Vaira, D., Bastens, B., Bataille, C., Serwir, B., Maes, B., Belaiche, J., & Groupe Liegeois d'études des Virus Hepatotropes. (December 2005). Hepatitis C virus genotype 5 in southern Belgium: Epidemiological characteristics and response to therapy. Digestive Diseases and Sciences, 50 (12), 2348-2351. doi:10.1007/s10620-005-3060-4
Peer Reviewed verified by ORBi

Lemey, P., Van Dooren, S., Van Laethem, K., Schrooten, Y., Derdelinckx, I., Goubau, P., Brun-Vezinet, F., Vaira, D., & Vandamme, A.-M. (14 October 2005). Molecular testing of multiple HIV-1 transmissions in a criminal case. AIDS, 19 (15), 1649-1658. doi:10.1097/01.aids.0000187904.02261.1a
Peer Reviewed verified by ORBi

Pinto, E., Gorwood, P., Reggers, J., Vaira, D., Fuchs, S., & Pitchot, W. (March 2005). Alcohol craving and the A1 allele of the D2 dopamine receptor gene. European Psychiatry, 20 (Suppl. 1), 25.
Peer Reviewed verified by ORBi

Gerard, C., Delwaide, J., Vaira, D., Bastens, B., Servais, B., Wain, E., Bataille, C., Daenen, G., & Belaiche, J. (2005). Evolution over a 10 year period of the epidemiological profile of 1,726 newly diagnosed HCV patients in Belgium. Journal of Medical Virology, 76 (4), 503-10. doi:10.1002/jmv.20390
Peer Reviewed verified by ORBi

Delwaide, J., Gerard, C., Vaira, D., Bastens, B., Servais, B., Wain, E., Bataille, C., Daenen, G., Detry, O., De Roover, A., Honoré, P., Meurisse, M., Rentier, B., & Belaiche, J. (January 2005). HCV genotypes 2 and 3: the predominant genotypes at the horizon 2020? Acta Gastro-Enterologica Belgica, 68 (1), 25.
Peer Reviewed verified by ORBi

Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., De Wit, S. P., Florence, E., Fransen, K., Ribas, S. G., Marissens, D., Moutschen, M., Vaira, D., Zissis, G., Van Ranst, M., Van Wijngaerden, E., & Vandamme, A.-M. (15 December 2004). Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response. Journal of Acquired Immune Deficiency Syndromes, 37 (5), 1664-1666. doi:10.1097/00126334-200412150-00022
Peer Reviewed verified by ORBi

Ziermann, R., Celis, L., Derdelinckx, I., Lambert, C., Veeck, J., Rizzo, M. G., Vanderborght, B., Zissis, G., Clumeck, N., Fransen, K., Vaira, D., Hendricks, D., Van Laethem, K., Vandamme, A.-M., Schmit, J.-C., Knechten, H., De Luca, A., Louwagie, J., Segers, P., ... Hulstaert, F. (December 2004). Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system. Journal of Clinical Virology, 31 (Suppl. 1), 7-S15. doi:10.1016/j.jcv.2004.09.014
Peer Reviewed verified by ORBi

El souda, R., DELWAIDE, J., GERARD, C., Belaiche, J., DE ROOVER, A., DETRY, O., Honoré, P., MEURISSE, M., Rentier, B., & VAIRA, D. (2004). Hpatitis C infection: eligibility for antiviral therapies. Acta Gastro-Enterologica Belgica, 67, 17.
Peer Reviewed verified by ORBi

REENAERS, C., DELWAIDE, J., GERARD, C., Bastens, B., Servais, B., Bekhti, A., Wain, E., DAENEN, G., Delforge, M., MESUREUR, T., Sente, B., Belaiche, J., DE ROOVER, A., DETRY, O., HONORE, P., MEURISSE, M., Rentier, B., & VAIRA, D. (2004). HCV genotype 4 in Belgium: epidemiological characteristics. Acta Gastro-Enterologica Belgica, (67), 03.
Peer Reviewed verified by ORBi

REENAERS, C., DELWAIDE, J., GERARD, C., Bastens, B., Bataille, C., BOEMER, F., Servais, B., BELAICHE, J., DE ROOVER, A., DETRY, O., HONORE, P., Meurisse, M., Rentier, B., & VAIRA, D. (2004). HCV genotype 5: an easy to treat population. Acta Gastro-Enterologica Belgica, 67, 15.
Peer Reviewed verified by ORBi

Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., De Schouwer, K., De Wit, S., Fransen, K., Garcia Ribas, S., Moutschen, M., Vaira, D., Zissis, G., Van Ranst, M., Van Wijngaerden, E., & Vandamme, A.-M. (28 November 2003). Performance of the VERSANT (R) HIV-1 Resistance Assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes. FEMS Immunology and Medical Microbiology, 39 (2), 119-124. doi:10.1016/S0928-8244(03)00240-2
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Hansenne, M., Pitchot, W., Fuchs, S., Gorwood, P., Vaira, D., & Ansseau, M. (September 2003). Relationships between DRD2 and DAT polymorphisms and personality traits in healthy subjects. European Neuropsychopharmacology, 13 (Suppl. 4), 427-S428. doi:10.1016/S0924-977X(03)92300-5
Peer Reviewed verified by ORBi

Servais, J., Hainaut, M., Schmitz, V., Maes, P., Fransen, E., Vaira, D., Brichard, B., Arendt, V., Schneider, F., Hemmer, R., & Schmit, J. C. (March 2002). Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor. Pediatric Infectious Disease Journal, 21 (3), 214-220. doi:10.1097/00006454-200203000-00011
Peer Reviewed verified by ORBi

Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., Dewit, S., Florence, E., Fransen, K., Ribas, S. G., Marissens, D., Moutschen, M., Van Wijngaerden, E., Vaira, D., Zissis, G., Van Ranst, M., & Vandamme, A.-M. (2002). Drug resistance among therapy-naive HIV-infected patients studied by sequencing and VERSANT (TM) HIV-1 resistance assays (LiPA) has limited impact on treatment response. Antiviral Therapy, 7 (Suppl. 1), 181.
Peer Reviewed verified by ORBi

Blaise, P., Clevenbergh, P., Vaira, D., Moutschen, M., & Dellamonica, P. (2002). HIV resistance to antiretroviral drugs: Mechanisms, genotypic and phenotypic resistance testing in clinical practice. Acta Clinica Belgica, 57 (4, Jul-Aug), 191-201. doi:10.1179/acb.2002.041
Peer Reviewed verified by ORBi

Hayette, M.-P., Vaira, D., Suzin, F., Boland, P., Christiaens, G., Melin, P., & De Mol, P. (June 2001). Detection of Aspergillus spp. by PCR in Bronchoalveolar Lavage Fluid. Journal of Clinical Microbiology, 39 (6), 2338-2340. doi:10.1128/JCM.39.6.2338-2340.2001
Peer Reviewed verified by ORBi

Gielen, S., Delwaide, J., Detry, O., Belaiche, J., Honore, P., Gerard, C., Maggipinto, G., Vaira, D., & Rentier, B. (2001). Comment je traite une ascite. Revue Médicale de Liège, 56 (12), 809-815.
Peer reviewed

Delwaide, J., Gerard, C., Belaiche, J., Maggipinto, G., Vaira, D., & Rentier, B. (2000). Evidence-Based Medicine: traitement de l'hépatite chronique C. GLEVHE. Groupe Liégeois d'Etude des Virus Hépatotropes. Revue Médicale de Liège, 55 (5), 337-340.
Peer reviewed

Delwaide, J., Gerard, C., Belaiche, J., Vaira, D., Maggipinto, G., & Rentier, B. (1999). La transmission du virus de l’hépatite C en milieu hospitalier. Médecine et Hygiène, 57, 1526-1529.
Peer Reviewed verified by ORBi

Lamproye, A., Delwaide, J., Vaira, D., Maggipinto, G., Gerard, C., Sondag, D., Rentier, B., Rorive, G., & Belaiche, J. (1999). Prevalence of hepatitis G virus in a haemodialysis unit. Acta Gastro-Enterologica Belgica, 62 (1), 13-15.
Peer Reviewed verified by ORBi

Delwaide, J., Bourgeois, N., Gerard, C., Wain, E., Vaira, D., & Belaiche, J. (1999). Treatment of acute hepatitis C with interferon alpha-2b prevents chronicity. Hepatology, 30 (4), 413.
Peer Reviewed verified by ORBi

Delwaide, J., Gerard, C., Vaira, D., Maggipinto, G., Rentier, B., & Belaiche, J. (1999). Hepatitis C virus transmission following invasive medical procedures [letter to the editor]. Journal of Internal Medicine, 245 (1), 107-108. doi:10.1046/j.1365-2796.1999.0444f.x
Peer Reviewed verified by ORBi

Gerard, C., Vaira, D., Delwaide, J., Lamproye, A., Maggipinto, G., Sondag, D., Rorive, G., Belaiche, J., & Rentier, B. (1998). Does HCV screening of blood donors affect transmission of hepatitis G virus in dialysed patients? Vox Sanguinis, 75 (1), 77-77. doi:10.1046/j.1423-0410.1998.7510077.x
Peer Reviewed verified by ORBi

Vaira, D., Forceille, C., Tsobo, C., Gerard, C., Sondag, D., & Rentier, B. (1998). Comparison of a PCR-based assay and the MT2 coculture method for the follow-up of syncytium inducing strains in HIV patients under antiprotease therapy [Paper presentation]. 12th International AIDS Conference, Geneva, Switzerland.

Gerard, C., Vaira, D., Delwaide, J., & Pirotte, J. (1998). Hépatite à virus G: mythe ou réalité? VHG/GBV-C: diagnostic, épidémiologie, risque transfusionnel et pathogénicité. Revue Médicale de Liège, 53 (9), 524-528.
Peer reviewed

DELWAIDE, J., Gerard, C., Vaira, D., Maggipinto, G., Rentier, B., & Belaiche, J. (1998). Transmission du virus de l'hépatite C par examens médicaux invasifs. Gastroentérologie Clinique et Biologique, 22 (2), 172.
Peer Reviewed verified by ORBi

Vaira, D., Delwaide, J., Lamproye, A., Maggipinto, G., Gerard, C., Rorive, G., Belaiche, J., SondagThull, D., & Rentier, B. (1997). Hepatitis G virus (HGV) prevalence in a Belgian population of chronic hemodialyzed patients. Gut, 41 (Suppl. 3), 129-A130.
Peer Reviewed verified by ORBi

Vaira, D., Delwaide, J., Lamproye, A., Maggipinto, G., Gerard, C., Rorive, G., Sondag, D., Rentier, B., & Belaiche, J. (1997). Prévalence du virus de l'hépatite G dans une population d'hémodialysés chroniques [Paper presentation]. XXIèmes Journées Francophones de Pathologie Digestive, Strasbourg, France.

Gerard, C., Vaira, D., Maggipinto, G., Troonen, H., Margraff, U., Siquet, J., & Sondag, D. (1996). Combination of Serological Markers to Predict the Presence or Absence of Viremia in Hcv-Seropositive Blood Donors. Vox Sanguinis, 71 (1), 58-60. doi:10.1046/j.1423-0410.1996.7110058.x
Peer Reviewed verified by ORBi

Legrand, S., Hoebeke, M., Vaira, D., Rentier, B., & Piette, J. (March 1993). HIV-1 promoter activation following an oxidative stress mediated by singlet oxygen. Journal of Photochemistry and Photobiology B: Biology, 17 (3), 229-237. doi:10.1016/1011-1344(93)80020-A
Peer Reviewed verified by ORBi

Legrand, S., Hoebeke, M., Vaira, D., Rentier, B., Van de Vorst, A., & Piette, J. (1992). HIV-1 reactivation after an oxidative stress. Archives Internationales de Physiologie, de Biochimie et de Biophysique, 100, 55.

Sadzot-Delvaux, C., Vaira, D., Snoeck, R., Balzarini, J., Andrei, G., Piette, J., Rentier, B., & De Clercq, E. (1992). Restriction endonuclease patterns of HSV-1 and HSV-2 DNA isolated from 2 patients with relapsing episodes [Poster presentation]. 17th International Herpesvirus Workshop, Edinburgh, United Kingdom.

Legrand, S., Vaira, D., Rentier, B., & Piette, J. (1992). HIV-1 reactivation after an oxidative stress. In LinkVIII International Conference on AIDS/III STD World Congress, Amsterdam, the Netherlands 19-24 July 1992. Amsterdam, Netherlands: CONGREX Holland B.V.

Legrand-Poels, S., VAIRA, D., PINCEMAIL, J., Van de Vorst, A., & Piette, J. (1990). Activation of human immunodeficiency virus type 1 by an oxidative stress. AIDS Research and Human Retroviruses. doi:10.1089/aid.1990.6.1389
Peer Reviewed verified by ORBi

Piette, J., Legrand-Poels, S., Vaira, D., Rentier, B., & Van de Vorst, A. (1990). Reactivation of HIV-1 after an oxidative stress. Free Radical Biology and Medicine, 9 (Suppl. A), 5.
Peer Reviewed verified by ORBi

Vaira, D., François-Gérard, C., Doppagne, A., Sondag, D., & Rentier, B. (1990). Diagnosis by PCR of HIV-1 infection in seronegative individuals at risk. AIDS Research and Human Retroviruses, 6 (2), 173-174. doi:10.1089/aid.1990.6.173
Peer Reviewed verified by ORBi

François-Gérard, C., Warling, C., Vaira, D., Rentier, B., Poplavsky, J. L., Reginster, M., & Sondag, D. (1989). Méthodes de détection de l'infection par le virus de l'immunodéficience humaine (HIV). Revue Médicale de Liège, 44 (8), 295-305.
Peer reviewed

Sadzot-Delvaux, C., Merville-Louis, M. P., Delrée, P., Marc, P., Vaira, D., Piette, J., Moonen, G., & Rentier, B. (1989). In vivo model of varicella-zoster virus latency in the nervous system [Paper presentation]. 14th International Herpesvirus Workshop, Nyborg, Denmark.

Vaira, D., Sondag, D., François-Gérard, C., Doppagne, A., & Rentier, B. (1989). Diagnosis of HIV-1 in African couples : comparison of serology and PCR. In Cinquième conférence internationale sur le SIDA : le défi scientifique et social (pp. 501-501). Ottawa, Canada: Centre de Recherches pour le Développement International.

Vaira, D., François-Gérard, C., Rentier, B., & Sondag, D. (1989). Absence of seroconversion in a PCR positive person 18 months after transfusion of HIV infected blood. Vox Sanguinis, 57 (3), 220-221. doi:10.1111/j.1423-0410.1989.tb00829.x
Peer Reviewed verified by ORBi

Vaira, D., François-Gérard, C., Sondag, D., & Rentier, B. (November 1988). Polymerase Chain Reaction [Paper presentation]. Eerste nationaal aids symposium : medische en psycho-sociale aspecten = premier symposium national sur le sida : aspects cliniques et psycho-sociaux, Brussels, Belgium.

François-Gérard, C., Vaira, D., Rentier, B., & Sondag, D. (1988). Interprétation du Western Blot (WB) [Paper presentation]. Eerste nationaal aids symposium : medische en psycho-sociale aspecten = premier symposium national sur le sida : aspects cliniques et psycho-sociaux, Brussels, Belgium.

Hainaut, P., Vaira, D., Calberg-Bacq, C.-M., François, C., Kozma, S., Sadzot-Delvaux, C., & Osterrieth, P. (1987). Resistance to exogenous MMTV infection in a strain of "Swiss" mice is correlated with the presence of an endogenous proviral gene, mtv-3 [Poster presentation]. Breast Cancer Research Conference, Miami, United States - Florida.

Hainaut, P., Vaira, D., Calberg-Bacq, C.-M., François, C., Heinen, E., Rentier, B., & Osterrieth, P. M. (1984). Natural infection of Swiss mice by the Mouse Mammary Tumor Virus (MMTV). 2. Studies on the pathway of infection. Archives Internationales de Physiologie et de Biochimie, 92 (1), 28.

Hainaut, P., Sadzot-Delvaux, C., Vaira, D., Calberg-Bacq, C.-M., & François, C. (1984). Antibodies to mouse mammary tumor virus (MMTV) antigens to gp52 and p28 in three lines of mice with different infectious status [Poster presentation]. XVth meeting of European Tumor Virus Group, Urbino, Italy.

Contact ORBi